Inhibition of AhR signaling decreases growth of prostate cancer cells. by Oliver Richmond (585233)

Non-response analysis. by Sebastian Starystach (8493531)

Combination metabolic therapy decreases VM-M3 cell proliferation <i>in vitro</i>. by A. M. Poff (752552)

“…<b>(B)</b> Combining low glucose, ketone supplementation, and HBOT resulted in a marked decrease in cell proliferation which was significant from control at all time points tested. …”

Decreased number of cones and retinal ganglion cells in Oc-deficient retina. by Michaela Kreplova (9239560)

Proliferation marker Ki-67 is decreased by rLOX-PP treatment. by Manish V. Bais (333481)

HAART decreases Viral Load and increases CD4 counts and percentages. by Pietro Presicce (144163)

<i>E. faecalis</i> metabolism decreases after exposure to bilirubin. by Christopher L. Nobles (437464)

Mutation of LHPLL in PPARα decreases PP-induced transcriptional activity by Eric S. Tien (22393)

SUI-sEVs decreased the migration ability of primary cultured fibroblasts. by Xiaoyan Sun (28501)

“…SUI-sEVs significant decreased the migration ability of primary cultured fibroblasts at 48h when compared to the cells in control group and treated with the non SUI-sEVs. …”

Inhibition of inflammatory signalling pathways decreases HSV-2 viral shedding. by Victor H. Ferreira (719813)

Predictive accuracy of the metastatic signature decreases for samples with low tumor percentage by Paul Roepman (68450)

Increases in 1,5-anhydrosorbitol and decreases in ascorbic acid following RYGB. by David M. Mutch (37665)

“…B) For ascorbic acid, the ANOVA model did not detect group-specific changes over time (no group:time interaction), but indicated significant decreases from T0 to T6 in both groups. Overall, 1,5-anhydrosorbitol and ascorbic acid were significantly different at each time point between OB and OB/D subgroups (p<0.01, see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0007905#pone-0007905-t002" target="_blank"><b>TABLE 2</b></a>).…”

The top genes with decreased histone H3 acetylation in TG striata. by Karen N. McFarland (146686)

Decreased expression of HATL5 mRNA and protein in human carcinomas. by Gregory S. Miller (519005)

The point mutants E559A, E563A and K567A display altered DNA-binding kinetics. by Bettina Hüntelmann (566945)

“…<p>(A–C) Binding affinity of the indicated STAT1-GFP fusion proteins to three different duplex oligonucleotides containing two strong GAS elements in tandem arrangement (2xGAS) or mutations thereof, with a single GAS element (GAS-nonGAS) or no GAS element (2xnonGAS). …”

PI+ CD3+ T cells decrease at day 14 after IR while PI+ CD3- cells decrease at all time points. by Jordan A. Gunning (18143970)

The p.I126S mutation decreases FOXC1 DNA-binding. by Cristina Medina-Trillo (705087)

TUT1 suppression yields broad decreases in miRNA expression. by Emily C. Knouf (434880)

“…(<b>A</b>) We compared the abundance of miRNAs detectable with at least 50 counts on the NanoString platform in the enzyme suppressed vs. negative control siRNA-transfected cells. …”

Primary endpoint analysis, i.e., time to first occurrence of combined event of 50% decrease in eGFR or ESRD. by Rozita Mohd (7411322)

Increased miR200c decreases FAP-1 expression. by Sabarinathan Ramachandran (444500)